A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Artemether | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Artemether. |
| Lumefantrine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Lumefantrine. |
| Nicotine | The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Nicotine. |
| Mecamylamine | The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Mecamylamine. |
| Pentolinium | The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Pentolinium. |
| Trimethaphan | The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Trimethaphan. |
| Hexamethonium | The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Hexamethonium. |
| Cyclopentamine | The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Cyclopentamine. |
| Methotrexate | The protein binding of Methotrexate can be increased when combined with Sulfadoxine. |
| Thiethylperazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Thiethylperazine. |
| Promazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Promazine. |
| Prochlorperazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Prochlorperazine. |
| Chlorpromazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Chlorpromazine. |
| Triflupromazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Triflupromazine. |
| Fluphenazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Fluphenazine. |
| Thioridazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Thioridazine. |
| Moricizine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Moricizine. |
| Trifluoperazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Trifluoperazine. |
| Perphenazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Perphenazine. |
| Mesoridazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Mesoridazine. |
| Acetophenazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Acetophenazine. |
| Promethazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Promethazine. |
| Alimemazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Alimemazine. |
| Methotrimeprazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Methotrimeprazine. |
| Periciazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Periciazine. |
| Acepromazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Acepromazine. |
| Aceprometazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Aceprometazine. |
| Pipotiazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Pipotiazine. |
| Thioproperazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Thioproperazine. |
| BL-1020 | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with BL-1020. |
| Cyamemazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Cyamemazine. |
| Methylene blue | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Methylene blue. |
| Propiopromazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Propiopromazine. |
| Perazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Perazine. |
| Butaperazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Butaperazine. |
| Chlorproethazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Chlorproethazine. |
| Thiazinam | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Thiazinam. |
| Dixyrazine | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Dixyrazine. |
| Perphenazine enanthate | The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Perphenazine enanthate. |
| Dapsone | The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Dapsone. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfadoxine. |
| Dexketoprofen | The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfadoxine. |
| Cyclosporine | The risk or severity of renal failure can be increased when Sulfadoxine is combined with Cyclosporine. |
| Vemurafenib | The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Sulfadoxine. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with Insulin glargine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with Insulin pork. |
| Troglitazone | The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfadoxine. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfadoxine. |
| Sulfisoxazole | The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfadoxine. |
| Disopyramide | The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfadoxine. |
| Acarbose | The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfadoxine. |
| Metformin | The therapeutic efficacy of Metformin can be increased when used in combination with Sulfadoxine. |
| Sulfadiazine | The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfadoxine. |
| Rosiglitazone | The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfadoxine. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfadoxine. |
| Quinine | The therapeutic efficacy of Quinine can be increased when used in combination with Sulfadoxine. |
| Miglitol | The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfadoxine. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfadoxine. |
| Nateglinide | The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfadoxine. |
| Pentamidine | The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfadoxine. |
| Mifepristone | The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfadoxine. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfadoxine. |
| Repaglinide | The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfadoxine. |
| Phenformin | The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfadoxine. |
| Sulfamethoxazole | The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfadoxine. |
| Glyburide | The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfadoxine. |
| Glipizide | The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfadoxine. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfadoxine. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfadoxine. |
| Pioglitazone | The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfadoxine. |
| Bromocriptine | The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfadoxine. |
| Gliquidone | The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfadoxine. |
| Mitiglinide | The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfadoxine. |
| Sitagliptin | The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfadoxine. |
| Sunitinib | The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfadoxine. |
| Exenatide | The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfadoxine. |
| Mecasermin | The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfadoxine. |
| Pramlintide | The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfadoxine. |
| Glisoxepide | The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfadoxine. |
| Insulin aspart | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with Insulin aspart. |
| Insulin detemir | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with Insulin detemir. |
| Insulin glulisine | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with Insulin glulisine. |
| Glymidine | The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfadoxine. |
| AICA ribonucleotide | The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfadoxine. |
| Buformin | The therapeutic efficacy of Buformin can be increased when used in combination with Sulfadoxine. |
| Vildagliptin | The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfadoxine. |
| Voglibose | The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfadoxine. |
| NN344 | The risk or severity of hypoglycemia can be increased when Sulfadoxine is combined with NN344. |
| AMG-222 | The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfadoxine. |
| Bisegliptin | The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfadoxine. |
| Alogliptin | The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfadoxine. |
| Dapagliflozin | The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfadoxine. |
| Saxagliptin | The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfadoxine. |
| Liraglutide | The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfadoxine. |
| Gosogliptin | The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfadoxine. |
| Linagliptin | The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfadoxine. |
| Canagliflozin | The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadoxine. |
| Glibornuride | The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfadoxine. |